← brief for 2026-10-13 · Slowing decline

Treatment Considerations for Selecting Biologic and Targeted Synthetic DMARDs in Patients with Rheumatoid Arthritis with Comorbidities: An Indian Perspective

Key takeaways

This paper discusses how to choose arthritis drugs for patients who also have other health issues, like kidney problems. It is a guide for doctors, not a new study. It helps with treatment planning in India.

Who did this work

Venkataraman Krishnamurthy (Apollo Hospitals) · Balebail G. Dharmanand (Center for Rheumatology) · Alakendu Ghosh (Institute of Neurosciences Kolkata) · Yojana A. Gokhale · Reena Sharma · Prasan Deep Rath (Max Super Speciality Hospital) · Sham Santhanam (Kasturba Medical College, Manipal) · Yogesh Sharma (Abbott (India))

Source

Article · OpenAlex, CKD works · 2026-10-12
https://doi.org/10.1177/09733698261490642